Nuvation Bio And 2 Penny Stocks To Own

Simply Wall St.10-23

Oil prices recently pushed above $111 a barrel after attacks on Saudi infrastructure and rising Iran risk, putting energy costs and inflation firmly back on the radar. Higher input prices can punish ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2677960752?lang=en_US&edition=fundamental","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351","is_english":true,"pubTime":"2026-10-23 00:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2677960752","market":"nz","top_or_hot":-1,"title":"Nuvation Bio And 2 Penny Stocks To Own","media":"Simply Wall St.","content":"<div>\n<p>Oil prices recently pushed above $111 a barrel after attacks on Saudi infrastructure and rising Iran risk, putting energy costs and inflation firmly back on the radar. Higher input prices can punish ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/nuvation-bio-and-2-penny-stocks-to-own\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nuvation Bio And 2 Penny Stocks To Own</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNuvation Bio And 2 Penny Stocks To Own\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-10-23 00:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/nuvation-bio-and-2-penny-stocks-to-own><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Oil prices recently pushed above $111 a barrel after attacks on Saudi infrastructure and rising Iran risk, putting energy costs and inflation firmly back on the radar. Higher input prices can punish ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/nuvation-bio-and-2-penny-stocks-to-own\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/nuvation-bio-and-2-penny-stocks-to-own","article_id":"2677960752","we_media_id":null,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/nuvation-bio-and-2-penny-stocks-to-own","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2677960752","pubTimestamp":1792687080,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Oil prices recently pushed above $111 a barrel after attacks on Saudi infrastructure and rising Iran risk, putting energy costs and inflation firmly back on the radar. Higher input prices can punish weak balance sheets and highly diluted plays. That is where a basket of sturdier, still cheap penny stocks with cleaner finances and strong growth forecasts becomes interesting. This article breaks down three of the strongest candidates from that group.\nThe stocks covered below are just a small...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","JVA":"Coffee Holding Co","BK4212":"包装食品与肉类","NUVB":"Nuvation Bio, Inc.","BK4141":"半导体产品","GUER":"Guerrilla RF, Inc."},"translate_title":"Nuvation Bio 和 2 只值得拥有的细价股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NUVB":1,"GUER":1,"JVA":1},"content_text":"Oil prices recently pushed above $111 a barrel after attacks on Saudi infrastructure and rising Iran risk, putting energy costs and inflation firmly back on the radar. Higher input prices can punish weak balance sheets and highly diluted plays. That is where a basket of sturdier, still cheap penny stocks with cleaner finances and strong growth forecasts becomes interesting. This article breaks down three of the strongest candidates from that group. The stocks covered below are just a small sample of this idea. The full screen surfaces 7 more companies with equally compelling stories that do not fit into a single article. To see the rest, head straight to the Elite Penny Stocks screener to identify, analyze, and focus on the highest-conviction plays. AdvertisementNuvation Bio (NUVB) Nuvation Bio is a clinical-stage oncology specialist in the Elite Penny Stocks screener theme, with its value tied directly to late-stage cancer drugs rather than mature cash flows. This puts extra focus on how durable and scalable those therapies can become. Nuvation Bio generates about $169.9 million from oncology development activities and has a market cap of roughly $1.67b, reflecting investor attention on its IBTROZI and safusidenib cancer programs rather than a diversified revenue mix. \"IBTROZI is rapidly emerging as the preferred therapy in ROS1 positive non small cell lung cancer, with best in class durability, strong brain penetration and growing first line use.\"There is also the question of what might happen if a single assumption about how quickly those treatments translate into sustained revenue growth and healthier margins proves too cautious. If that shift in assumptions matters to you, read the full narrative for Nuvation Bio to see whether the current story is masking upside or underestimating risk. NYSE:NUVB Earnings & Revenue History as at Oct 2026 Guerrilla RF (GUER) Guerrilla RF is a fabless RF semiconductor player that designs and sells monolithic microwave integrated circuits used in wireless infrastructure, automotive and other connectivity markets, generating about $27 million from high performance connectivity products and carrying a market cap of roughly $43 million. Guerrilla RF lines up with the Elite Penny Stocks theme as a small RF specialist tied directly to 4G and 5G infrastructure demand, yet priced at a P/S of 1.6x against peers around 4x and growth forecasts near 27% a year. Investor interest centers on how this revenue profile interacts with the company’s operating leverage over time. To see how that trade off between Guerrilla RF’s 1.6x P/S and peer multiples could be decoupling from fundamentals, pull up the DCF valuation analysis for Guerrilla RF for the full picture. OTCPK:GUER P/S Ratio as at Oct 2026 Coffee Holding (JVA) Coffee Holding runs a vertically integrated roasted and blended coffee business that manufactures, packages, and supplies branded and private-label products, including single-cup pods, to retailers and foodservice customers. It generates about $97 million from coffee sales and has a market cap near $27 million. Coffee Holding lines up cleanly with the Elite Penny Stocks theme because its wholesale and private-label roasted coffee engine is already producing stronger earnings, with net profit margins at 4.9% and earnings up 154.4% last year. The new buyback program now more directly affects what happens if one key pressure on those margins shifts. That margin pressure is where Coffee Holding gets interesting, so pull up the analysis report for Coffee Holding to see whether those earnings are masking a deeper re-rating story. NasdaqCM:JVA Revenue & Expenses Breakdown as at Oct 2026 Seeking Alternatives Before The Crowd? Fresh opportunities rarely stay quiet for long. Momentum shifts, potential breakouts get noticed, and under the radar for now ideas are quickly caught. Scan what is flying before it drops and act now.  Spot potential early compounders by checking the 21 high quality undiscovered gems curated for solid fundamentals before they drift onto everyone else’s radar. Track cash rich operators by reviewing the list of solid balance sheet and fundamentals (25 results) so you focus on sturdier businesses while that financial strength still goes underpriced. Ride structural demand shifts by scanning the 16 nuclear energy infrastructure stocks curated for infrastructure players that could build long runway exposure while it still looks overlooked.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Nuvation Bio might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2677960752","isCrawlerRequest":true}